טוען...
Switching away from pipotiazine palmitate: a naturalistic study
BACKGROUND: In March 2015, pipotiazine palmitate depot antipsychotic was globally withdrawn due to the shortage of its active ingredient. Thus, all patients receiving this medication had to be switched to an alternative antipsychotic drug. In this study we set to evaluate the process of switching aw...
שמור ב:
| הוצא לאור ב: | Ther Adv Psychopharmacol |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5228718/ https://ncbi.nlm.nih.gov/pubmed/28101321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125316672575 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|